Interview with Denisa Timkova, General Manager, Cegedim Hungary
Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…
Address: Krisztina krt. 39/b H-1013 Budapest,Hungary
Tel: +36 1 487 3100
Web: http://www.cegedim.com/Pages/default.aspx
Founded in 1969, Cegedim is an innovation-led global technology and services company specializing
in the healthcare field.
Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life
Cegedim supplies services, technological tools, specialized software, data flow management services and databases
Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies.
The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data.
Cegedim employs 8,500 people in more than 80 countries and generated revenue of €927 million in 2010.
The Cegedim Group’s services have strong synergies that are combined in three sectors of activity.
1.CRM and strategic data
CRM, compliance and marketing solutions, databases, market research studies… for the life sciences industry.
2.Healthcare professionnals
Software publishing, healthcare networks, promotional information… dedicated to doctors, pharmacists and paramedics
3.Insurances and services
IT for healthcare insurers, data flow management, outsourced solutions… for companies of all sectors
Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…
Providing universal health coverage to the nation’s roughly 10 million citizens, Hungary’s National Health Insurance Fund (OEP) has one of the most comprehensive and complex structures in Europe. The organization’s…
Chronic underfinancing is a common pitfall for many former socialist states and Hungary is no exception. Total health spending ultimately accounted for 8.0 percent of GDP in Hungary in 2014, which…
Mylan Hungary’s Tamas Uri discusses transitioning into both a branded and generic business dedicated company, Mylan’s expansion in Hungary, and how the pharmaceutical industry can be a key player in improving the…
Hungary’s Minister of Foreign Affairs and Trade Péter Szijjártó highlights the significant role that foreign direct investments have played in developing the country’s healthcare and life science sector, while detailing…
György Bodoky, Head of the Oncology Department at Unified Szent István and Szent László Hospital, shares his insights on the state of oncological care in Hungary, the current effects of…
János Burovincz, Managing Director of Patent, shares his insights on building a company from scratch, the importance of maintaining a diverse portfolio that can quickly adapt to market needs as…
GSK Hungary’s Claire Roger discusses the value of ethical promotion both in improving transparency and benefiting all stakeholders. She further describes the strategic role and economic impact of GSK’s vaccine plant in…
Róbert Ésik, President of the Hungarian Investment Promotion Agency (HIPA), shares his insights into what makes Hungary such an attractive destination for foreign direct investment and ways that the agency…
To effectively reform old habits requires diligence, consistency and, above all, patience. As an introduction for our readers, could you describe the initial objectives that you set for yourself…
Veronika Ferencz, Sales and Marketing Director for Exeltis Hungary, discusses the evolving and expanding footprint of the company in Hungary, the challenges strict regulations on food supplements are causing, as…
The leadership of Meditop discuss their history as the first non-privatized, private Hungarian pharmaceutical company, their ongoing strategies for growth in the country, and their evolving portfolio abroad. They also…
The recently appointed CEO of Servier Hungary, Dr. Jan Frederic Kesselhut highlights his initial perceptions of the Hungarian pharmaceutical market and depicts the significant role that the Servier Research Institute…
See our Cookie Privacy Policy Here
